(NYSEMKT: AZTR) Azitra's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.6%.
Azitra's earnings in 2025 is -$11,114,999.On average, 4 Wall Street analysts forecast AZTR's earnings for 2025 to be -$34,349,821, with the lowest AZTR earnings forecast at -$39,303,298, and the highest AZTR earnings forecast at -$28,609,544. On average, 4 Wall Street analysts forecast AZTR's earnings for 2026 to be -$21,286,480, with the lowest AZTR earnings forecast at -$32,102,694, and the highest AZTR earnings forecast at -$9,429,363.
In 2027, AZTR is forecast to generate -$39,202,269 in earnings, with the lowest earnings forecast at -$42,628,067 and the highest earnings forecast at -$35,038,655.